Clinical trial
Obese Patients With Untreated Dyslipidemias
NCT00029835 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00029835 |
|---|---|
| Title | Obese Patients With Untreated Dyslipidemias |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias |
| Acronym | RIO-Lipids |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity, Dyslipidemia |
| Intervention type | Drug |
| Interventions | Rimonabant (SR141716) |
| Enrollment | 1,033 |
| Start date | Sep 1, 2001 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Jan 24, 2002 |
| Last update posted | Apr 20, 2009 |
| Countries | Australia, Canada, Finland, Italy, Spain, Sweden, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: